Kim Lawson
Sheffield Hallam University
Lecturer, Life Sciences
United Kingdom
My co-authors include
Simon Ashe
My Publications
Pharmacology and clinical applications of flupirtine: Current and future options
World Journal of Pharmacology
January 2019
Kv7 channels a potential therapeutic target in fibromyalgia: A hypothesis
World Journal of Pharmacology
October 2018
Patients’ perspective of effectiveness & acceptability of treatments of fibromyalgia
Scandinavian Journal of Pain
October 2018
Flupirtine an Effective Analgesic: Is the Associated Rare Liver Injury a Limiting Factor?
Anesthesia & Analgesia
August 2018
What causes fibromyalgia? An online survey of patient perspectives
Health Psychology Open
July 2018
The experience of living with Fibromyalgia in the UK.
Health Psychology Open
July 2017
Pharmacology of Amitriptyline and Clinical Outcomes in Treating Fibromyalgia
Biomedicines
May 2017
Emerging pharmacological strategies for the treatment of fibromyalgia
World Journal of Pharmacology
January 2017
Potential drug therapies for the treatment of fibromyalgia
Expert Opinion on Investigational Drugs
June 2016
Clinical Trials for Patients with Fibromyalgia Syndrome
Clinical and Experimental Pharmacology
January 2014
Innovative Approaches for the Complexity of Fibromyalgia
Clinical and Experimental Pharmacology
January 2013
Phasic activity of urinary bladder smooth muscle in the streptozotocin-induced diabetic...
European Journal of Pharmacology
June 2011
The role of c-kit-positive interstitial cells in mediating phasic contractions of bladd...
British Journal of Urology
August 2010
Treatment options and patient perspectives in the management of fibromyalgia: future tr...
Neuropsychiatric Disease and Treatment
November 2008
Pharmacological treatments of fibromyalgia: Do complex conditions need complex therapies?
Drug Discovery Today
April 2008
Rubidium Efflux as a Tool for the Pharmacological Characterisation of Compounds with BK...
January 2008
Are complex therapies required as pharmacological treatments of fibromyalgia?
Future Rheumatology
December 2007
Potassium Channels as Targets for the Management of Pain
Central Nervous System Agents in Medicinal Chemistry
June 2006
Increasing awareness and recognition of fibromyalgia
British Journal of Therapy and Rehabilitation
June 2003
Tricyclic antidepressants and fibromyalgia: what is the mechanism of action?
Expert Opinion on Investigational Drugs
October 2002
Peripheral channelopathies as targets for potassium channel openers
Expert Opinion on Investigational Drugs
July 2001
The Pharmacotherapy of Common Functional Syndromes
Physiotherapy
February 2001
Is there a role for potassium channel openers in neuronal ion channel disorders?
Expert Opinion on Investigational Drugs
October 2000
Potassium channel openers as potential therapeutic weapons in ion channel disease
Kidney International
March 2000
Therapeutic Applications of Anti-depressant Drugs in Fibromyalgia Syndrome
Physiotherapy
April 1999
Tizanidine
Physiotherapy
September 1998
Is there a Therapeutic Future for ‘Potassium Channel Openers’?
Clinical Science
December 1996
Potassium channel activation: A potential therapeutic approach?
Pharmacology & Therapeutics
January 1996
Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and n...
British Journal of Pharmacology
September 1992
Contractile responses to calcium chloride in rat aortic rings bathed in K+-free solutio...
British Journal of Pharmacology
January 1989
